Hudson Hannah R, Sun Xuehan, Orr Miranda E
Department of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, NC, USA; Department of Neurology, Washington University School of Medicine in St Louis, MO, USA.
Department of Neurology, Washington University School of Medicine in St Louis, MO, USA.
Neurotherapeutics. 2025 Apr;22(3):e00519. doi: 10.1016/j.neurot.2024.e00519. Epub 2025 Jan 6.
Cellular senescence is a cell state triggered by programmed physiological processes or cellular stress responses. Stress-induced senescent cells often acquire pathogenic traits, including a toxic secretome and resistance to apoptosis. When pathogenic senescent cells form faster than they are cleared by the immune system, they accumulate in tissues throughout the body and contribute to age-related diseases, including neurodegeneration. This review highlights evidence of pathogenic senescent cells in the brain and their role in Alzheimer's disease (AD), the leading cause of dementia in older adults. We also discuss the progress and challenges of senotherapies, pharmacological strategies to clear senescent cells or mitigate their toxic effects, which hold promise as interventions for AD and related dementias (ADRD).
细胞衰老 是一种由程序性生理过程或细胞应激反应触发的细胞状态。应激诱导的衰老细胞通常会获得致病特性,包括毒性分泌组和对细胞凋亡的抗性。当致病性衰老细胞形成的速度快于它们被免疫系统清除的速度时,它们会在全身组织中积累,并导致与年龄相关的疾病,包括神经退行性变。这篇综述重点介绍了大脑中致病性衰老细胞的证据及其在阿尔茨海默病(AD)中的作用,AD是老年人痴呆的主要原因。我们还讨论了衰老疗法的进展和挑战,衰老疗法是清除衰老细胞或减轻其毒性作用的药理学策略,有望作为AD和相关痴呆症(ADRD)的干预措施。